Results 251 to 260 of about 282,881 (309)

Unmasking the 'rods and rings' antinuclear antibody pattern: a sign of hepatitis C treatment and a risk factor for cerebrovascular disease. [PDF]

Ann Med
Lin KM, Yu KH, Hsiao CY, Su YJ, Chan TM.
europepmc   +1 more source

Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant. [PDF]

J Gen Virol
Dislers A, Nilova O, Jansons J, Skrastina D, Bogans J, Petrovskis I, Spunde K, Stepanovs R, Kazaks A, Zajakina A, Sominskaya I.   +10 more
europepmc   +1 more source

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy. [PDF]

Liver Int
Kirchner T, Dalekos GN, Zachou K, Robles-Díaz M, Andrade RJ, Sebode M, Lohse A, Janik MK, Milkiewicz P, Kolev M, Semmo N, Bruns T, Gevers TJ, Beretta-Piccoli BT, Wedemeyer H, Jaeckel E, Taubert R, Engel B, pIgG study group.   +18 more
europepmc   +1 more source

Hepatitis C virus and hepatitis B virus in indolent lymphomas: Prospective data from the international observational NF10 study

British Journal of Haematology, EarlyView.
Luca Arcaini, Michele Merli, Sara Rattotti, Maria Elena Nizzoli, Vittoria Tarantino, Chiara Consoli, Annalisa Talami, Roberta Murru, Marina Deodato, Emanuele Cencini, Francesca Re, Carlo Visco, Guilherme Duffles, Michele Spina, Ombretta Annibali, Alessandro Pulsoni, Andrés J. M. Ferreri, Caterina Stelitano, Elsa Pennese, Marzia Varettoni, Emilia Cappello, Gianmarco Favrin, Martina La Fauci, Luigi Marcheselli, Marco Paulli, Stefano Luminari   +25 more
wiley   +1 more source

Auto-antibodies in hepatitis C

Biomedicine and Pharmacotherapy, 1999
Hepatitis C virus (HCV) has been implicated in the development of a variety of autoimmune phenomena, some of which are well documented and include a panel of auto-antibodies shared with autoimmune hepatitis (AIH). Anti-nuclear (ANA) and smooth muscle (SMA) antibodies (markers of AIH type 1 [AIH-1]), have been demonstrated in 9-38% and 5-91% of cases ...
D Zauli, F Cassani, F B Bianchi
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Antibodies to hepatitis C virus and hepatitis C virus infection

Gastroenterologia Japonica, 1993
The authors studied the interrelationship of antibody to hepatitis C virus core protein (anti-HCV core), antibody to C100-3 antigen (anti-C100-3) and serum hepatitis C virus RNA positivity in chronic liver disease patients. Anti-HCVcore was detected with high titers in 95% (69/73) of chronic non-A, non-B hepatitis patients, while anti-C100-3 was found ...
N, Yuki, N, Hayashi, A, Kasahara, H, Hagiwara, H, Fusamoto, T, Kamada   +5 more
openaire   +2 more sources

Antibody to Hepatitis C Virus in Post-Transfusion Hepatitis

Annals of Internal Medicine, 1991
To evaluate the prevalence of antibodies to hepatitis C virus (anti-HCV), their relation to outcome, and the seroconversion rate in patients with post-transfusion non-A, non-B hepatitis.Retrospective analysis of prospectively collected serum specimens.A referral-based university hospital.Sixty-three consecutive patients who developed non-A, non-B post ...
Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, ALBERTI, ALFREDO, Ruol A.   +6 more
openaire   +4 more sources

Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg

Hepatology, 1993
Screening of blood donors by testing for antibody to HBcAg and antibody to hepatitis C virus is commonly done. However, the applicability of these screening tests may vary depending on the prevalence of hepatitis B virus and hepatitis C virus infection in various populations. We have therefore prospectively evaluated 158 adult
H T, Chung, J S, Lee, A S, Lok
openaire   +3 more sources

Hepatitis C Virus Antibody in Poland

Scandinavian Journal of Infectious Diseases, 1991
To assess the epidemiology of hepatitis C virus (HCV) in Poland, anti-HCV was studied in patients with acute and chronic non-A, non-B (NANB) hepatitis, in healthy adults, and in subjects at risk. Anti-HCV prevalence was 2% in 152 blood donors, 78% in 95 parenteral drug addicts, 21% in 112 alcoholics, and 86% in 42 patients with chronic NANB hepatitis ...
T, Laskus, M, Radkowski, E, Lupa, J, Cianciara, J, Slusarczyk, G, Halama, A, Horban   +6 more
openaire   +2 more sources